BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1494071)

  • 1. Effect of subject age on costs of screening for colorectal cancer.
    Whynes DK; Walker AR; Hardcastle JD
    J Epidemiol Community Health; 1992 Dec; 46(6):577-81. PubMed ID: 1494071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost of screening for colorectal cancer.
    Walker A; Whynes DK; Chamberlain JO; Hardcastle JD
    J Epidemiol Community Health; 1991 Sep; 45(3):220-4. PubMed ID: 1757765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J; Halloran S; Gray A
    BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of screening for colorectal cancer: evidence from the Nottingham faecal occult blood trial.
    Whynes DK;
    J Med Screen; 2004; 11(1):11-5. PubMed ID: 15006108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost savings in mass population screening for colorectal cancer resulting from the early detection and excision of adenomas.
    Whynes DK; Walker AR; Hardcastle JD
    Health Econ; 1992 Apr; 1(1):53-60. PubMed ID: 1342630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
    Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
    Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Planning for a possible national colorectal cancer screening programme.
    Garvican L
    J Med Screen; 1998; 5(4):187-94. PubMed ID: 9934649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for colorectal cancer: a general-practice-based study.
    Marjoram J; Strachan R; Allan A; Allan E
    Br J Gen Pract; 1996 May; 46(406):283-86. PubMed ID: 8762743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of CT colonography for UK NHS colorectal cancer screening of asymptomatic adults aged 60-69 years.
    Lee D; Muston D; Sweet A; Cunningham C; Slater A; Lock K
    Appl Health Econ Health Policy; 2010; 8(3):141-54. PubMed ID: 20369905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of CT colonography for colorectal cancer screening on the UK NHS: costs, healthcare resources and health outcomes.
    Sweet A; Lee D; Gairy K; Phiri D; Reason T; Lock K
    Appl Health Econ Health Policy; 2011; 9(1):51-64. PubMed ID: 21174482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for colorectal cancer: what are the costs?
    Weller D; Moss J; Hiller J; Thomas D; Edwards J
    Int J Technol Assess Health Care; 1995; 11(1):26-39. PubMed ID: 7706012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal Cancer Screening: How Health Gains and Cost-Effectiveness Vary by Ethnic Group, the Impact on Health Inequalities, and the Optimal Age Range to Screen.
    McLeod M; Kvizhinadze G; Boyd M; Barendregt J; Sarfati D; Wilson N; Blakely T
    Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1391-1400. PubMed ID: 28626068
    [No Abstract]   [Full Text] [Related]  

  • 15. Endoscopic colorectal cancer screening: a cost-saving analysis.
    Loeve F; Brown ML; Boer R; van Ballegooijen M; van Oortmarssen GJ; Habbema JD
    J Natl Cancer Inst; 2000 Apr; 92(7):557-63. PubMed ID: 10749911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-saving analysis of screening colonoscopy in Germany.
    Sieg A; Brenner H
    Z Gastroenterol; 2007 Sep; 45(9):945-51. PubMed ID: 17874356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal occult blood screening for colorectal cancer: is it cost-effective?
    Whynes DK; Neilson AR; Walker AR; Hardcastle JD
    Health Econ; 1998 Feb; 7(1):21-9. PubMed ID: 9541081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Health economics analysis of colorectal screening].
    Boncz I; Sebestyén A; Dózsa C; Pál M; Sándor J; Palásti J; Betlehem J; Ember I
    Magy Onkol; 2004; 48(2):111-5. PubMed ID: 15351803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals.
    Ladabaum U; Mannalithara A; Jandorf L; Itzkowitz SH
    Cancer; 2015 Apr; 121(7):1088-97. PubMed ID: 25492455
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.